Antimicrobial use in children under five years with diarrhea in a central region province, Thailand

N Howteerakul1, N Higginbotham, M J Dibley

  • 1Department of Epidemiology, Faculty of Public Health, Mahidol University, Australia. npp92432@yahoo.com

Insights

Appropriate antimicrobial prescribing for childhood diarrhea was low at 27.4%. Interventions are needed to improve physician knowledge and community use of oral rehydration therapy (ORT) to reduce inappropriate antimicrobial use.

Area of Science:

  • Infectious Diseases
  • Pediatrics
  • Pharmacology

Background:

  • Childhood diarrhea remains a significant health concern globally.
  • Antimicrobial resistance is a growing threat, necessitating judicious use of these agents.
  • Appropriate prescribing practices for pediatric diarrhea are crucial for effective treatment and resistance mitigation.

Purpose of the Study:

  • To determine the prevalence of appropriate antimicrobial prescribing for childhood diarrhea in a Thai public hospital system.
  • To identify prescribing patterns and commonly used antimicrobial agents.
  • To provide data for interventions aimed at improving diarrhea management.

Main Methods:

  • A prospective clinical audit was conducted on 424 pediatric diarrhea cases.
  • Physicians' prescribing practices were evaluated against predefined criteria for appropriate antimicrobial use.
  • Stool sample cultures were performed to identify causative pathogens.

Main Results:

  • Only 27.4% of cases received appropriate antimicrobial treatment based on clinical presentation.
  • Invasive bacterial-type diarrhea accounted for 12.5% of cases.
  • Commonly prescribed antimicrobials included cotrimoxazole, colistin sulfate, and norfloxacin, with a trend towards norfloxacin use.
  • Inpatients received a higher average number of antimicrobials compared to outpatients.

Conclusions:

  • There is a substantial need to improve antimicrobial prescribing for childhood diarrhea in the studied setting.
  • Educational interventions targeting physicians' knowledge of diarrhea treatment guidelines are recommended.
  • Promoting community awareness and correct use of oral rehydration therapy (ORT) is essential to reduce unnecessary antimicrobial prescriptions.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...